{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T10:06:41Z","timestamp":1779790001921,"version":"3.53.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"DFG"},{"name":"IZKF"},{"name":"Universit\u00e4tsklinikum W\u00fcrzburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Electrical cardioversion (ECV) is an effective treatment for restoring sinus rhythm in supraventricular tachycardias such as atrial fibrillation (AFib) and atrial flutter (AFlu). In clinical practice, serum potassium is often adjusted towards the upper normal range prior to ECV, although evidence supporting a beneficial effect on acute cardioversion success is limited. This study investigated whether serum potassium levels within the normal range influence immediate ECV outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective single-center cohort study including adult patients who underwent ECV for AFib, AFlu, or focal atrial tachycardia between 2019 and 2024. Patients with hypokalemia, hyperkalemia, recent potassium-altering interventions or missing potassium values were excluded. Serum potassium was categorized as low\u00a0normal (3.5\u20134.4\u00a0mmol\/l) or high\u00a0normal (4.5\u20135.5\u00a0mmol\/l). Immediate ECV success was defined as restoration of a stable sinus rhythm documented by a 12-lead ECG. Secondary outcomes included restoration and maintenance of sinus rhythm at discharge.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 647 patients were analyzed (48.5% low-normal vs. 51.5% high-normal potassium). Immediate ECV success rates were similar between groups (88.2% vs. 87.1%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.66), and potassium levels did not differ between successful and unsuccessful cardioversions (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.55). Potassium was not predictive of immediate ECV success and not associated with the shock number or maximum energy applied (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.563 and\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.836).). At discharge, sinus rhythm rates were comparable between groups (80.3% vs. 80.8%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.87). Again, potassium was not different between patients with successful and unsuccessful cardioversion (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.62). Subgroup analyses across predefined normokalemic ranges showed no significant associations regarding immediate ECV success as well as ECV success at discharge (each\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&gt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Serum potassium levels within the normal range do not influence immediate or short-term success of electrical cardioversion in patients with atrial fibrillation or atrial flutter. These findings suggest that routine potassium optimization beyond correction of abnormal values is unlikely to improve acute ECV outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00392-026-02944-0","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T09:51:10Z","timestamp":1779789070000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of serum potassium levels on success of electrical cardioversion in atrial fibrillation"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4692-7605","authenticated-orcid":false,"given":"Manuel J.","family":"Vogel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kilian","family":"Hacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Herting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz T.","family":"Huttelmaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Frantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas H.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"issue":"3","key":"2944_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/CIRCEP.116.004667","volume":"10","author":"JN Weiss","year":"2017","unstructured":"Weiss JN, Qu Z, Shivkumar K, Angeles L, Angeles L, Sciences R et al (2017) The electrophysiology of hypo- and hyperkalemia. Circ Arrhythmia Electrophysiol 10(3):1\u201321","journal-title":"Circ Arrhythmia Electrophysiol"},{"issue":"36","key":"2944_CR2","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","volume":"45","author":"IC Van Gelder","year":"2024","unstructured":"Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns HJGM et al (2024Sep 29) 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 45(36):3314\u20133414","journal-title":"Eur Heart J"},{"issue":"20","key":"2944_CR3","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1056\/NEJMoa2509542","volume":"393","author":"SSV Hashemi","year":"2025","unstructured":"Hashemi SSV, Haugan KJ, Ph D, Bruun NE, Sc DM (2025) Increasing the potassium level in patients at high risk for ventricular arrhythmias. N Engl J Med 393(20):1979\u20131989","journal-title":"N Engl J Med"},{"issue":"5","key":"2944_CR4","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.amjcard.2016.11.026","volume":"119","author":"S Jaakkola","year":"2016","unstructured":"Jaakkola S, Lip GYH, Biancari F, Nuotio I (2016) Predicting unsuccessful electrical cardioversion for acute atrial fibrillation ( from the AF-CVS Score ). Am J Cardiol 119(5):749\u2013752","journal-title":"Am J Cardiol"},{"issue":"12","key":"2944_CR5","first-page":"979","volume":"332","author":"BO Brien","year":"2026","unstructured":"Brien BO, Campbell NG, Allen E, Jamal Z, Sturgess J, Sanders J et al (2026) Potassium supplementation and prevention of atrial fibrillation after cardiac surgery: The TIGHT K Randomized Clinical Trial. JAMA 332(12):979\u2013988","journal-title":"JAMA"},{"key":"2944_CR6","first-page":"155","volume":"2019","author":"A Voskoboinik","year":"2018","unstructured":"Voskoboinik A, Plunkett G, Moskovitch J, Bloom J, Wong G, Yee C et al\u00a0 (2018) Cardioversion of atrial fibrillation in obese patients\u202f: results from the Cardioversion - BMI randomized controlled trial. J Cardiovasc Elektrophysiol 155\u2013161","journal-title":"J Cardiovasc Electrophysiol."},{"issue":"10","key":"2944_CR7","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.amjcard.2006.12.074","volume":"99","author":"ML Loricchio","year":"2007","unstructured":"Loricchio ML, Cianfrocca C, Pasceri V, Pandozi C, Palamara A, Santini M (2007) Relation of C-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion. Am J Cardiol 99(10):1421\u20131424","journal-title":"Am J Cardiol"},{"key":"2944_CR8","doi-asserted-by":"crossref","unstructured":"Hagengaard L, S\u00f8gaard P, Espersen M, Sessa M, Torp-pedersen C, Lund PE et al (2020) Association between serum potassium levels and short-term mortality in patients with atrial fibrillation or flutter co-treated with diuretics and rate- or rhythm-controlling drugs.  Eur Heart J Cardiovasc Pharmacother 6(3):137\u201344","DOI":"10.1093\/ehjcvp\/pvz024"},{"key":"2944_CR9","doi-asserted-by":"crossref","unstructured":"Elhendy A, Gentile F, Khandheria BK, Hammill SC, Gersh BJ, Bailey KR, et al. (2002) Predictors of unsuccessful electrical cardioversion in atrial fibrillation. Am J Cardiol 100(01):83\u20136","DOI":"10.1016\/S0002-9149(01)02172-5"},{"key":"2944_CR10","doi-asserted-by":"crossref","unstructured":"Hellman T, Kiviniemi T, Vasankari T, Nuotio I, Biancari F, Bah A, et al (2017) Prediction of ineffective elective cardioversion of atrial fibrillation\u202f: a retrospective multi-center patient cohort study. BMC Cardiovasc Disord 17(1):33","DOI":"10.1186\/s12872-017-0470-0"},{"key":"2944_CR11","doi-asserted-by":"crossref","unstructured":"Kyo M, Hosokawa K, Ohshimo S (2019) High serum potassium level is associated with successful electrical cardioversion for new-onset atrial fibrillation in the intensive care unit\u202f: a retrospective observational study. Anaesth Intensive Care 47(1):52-59","DOI":"10.1177\/0310057X18811815"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-026-02944-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-026-02944-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-026-02944-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T09:51:12Z","timestamp":1779789072000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-026-02944-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":11,"alternative-id":["2944"],"URL":"https:\/\/doi.org\/10.1007\/s00392-026-02944-0","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"assertion":[{"value":"20 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}